Lifeboat Foundation

Nature News reports of a growing concern over different standards for DNA screening and biosecurity:

“A standards war is brewing in the gene-synthesis industry. At stake is the way that the industry screens orders for hazardous toxins and genes, such as pieces of deadly viruses and bacteria. Two competing groups of companies are now proposing different sets of screening standards, and the results could be crucial for global biosecurity.

“If you have a company that persists with a lower standard, you can drag the industry down to a lower level,” says lawyer Stephen Maurer of the University of California, Berkeley, who is studying how the industry is developing responsible practices. “Now we have a standards war that is a race to the bottom.”

Continue reading “Keeping genes out of terrorists' hands” »

Abstract:

President Obama disbanded the President’s Council on Bioethics after it questioned his policy on embryonic stem cell research. White House press officer Reid Cherlin said that this was because the Council favored discussion over developing a shared consensus. This column lists a number of problems with Obama’s decision, and with his position on the most controversial bioethical issue of our time.

Bioethics and the End of Discussion

In early June, President Obama disbanded the President’s Council on Bioethics. According to White House press officer Reid Cherlin, this was because the Council was designed by the Bush administration to be “a philosophically leaning advisory group” that favored discussion over developing a shared consensus. http://www.nytimes.com/2009/06/18/us/politics/18ethics.html?_r=2

Continue reading “Bioethics and the End of Discussion” »

Unique opportunity to sponsor research investigating an infectious cause and potential treatment for Alzheimer’s disease

In these financially difficult times many funding bodies have to prioritise projects based around long established hypotheses. Projects involving new avenues of investigation can receive very positive comments by scientific reviewers, yet are rarely funded, as they almost always appear risky compared with projects largely confirming or expanding existing ideas. Such conservative projects are almost guaranteed to produce useful data, though with modest impact. This situation can mean that research proposals with the potential to transform our understanding of a disease and offer new approaches to its treatment never reach the threshold for funding and are not implemented, even though the potential and quality of the science is acknowledged by reviewers and funding panel.

It appears that our work examining a viral cause for Alzheimer’s disease is in this category. Despite our publishing a large number of potentially very exciting papers on this topic, and despite our research projects being reviewed favourably by scientific referees, few funding panels are prepared to commit resources to fund our work, as by doing so they deny funding to other more straightforward, very low risk projects.

We are therefore actively seeking sponsorship for several projects of varying costs to investigate the interaction of virus and specific genetic factor, the pathways of viral damage in the brain, and the effects of antiviral agents. All the projects would provide significant evidence strengthening the case for trialling antiviral agents in Alzheimer’s disease.

Antiviral agents would inhibit a likely major cause of the disease in contrast to current treatments, which merely inhibit the symptoms.

If any Lifeboat member knows of a company or individual that would be interested in sponsoring some of our research on Alzheimer’s disease then please contact me for further details.

Ruth Itzhaki

Continue reading “Unique opportunity to sponsor research investigating an infectious cause and potential treatment for Alzheimer’s disease” »

The air is buzzing. People are talking about health more than ever before, and it’s good news for patients. Technology is making it possible for patients to take an active role in “participatory medicine”, partnering with their doctors to decide on the best course of action for their health.

Over the next few months, these 6 events will bring together patients, researchers, doctors, and health enthusiasts. Discussions, partnerships, and innovations will emerge. Keep your eye on these, and attend if you can!

1. TEDMED — October 27–30, http://www.tedmed.com
The medical version of the legendary TED conferences. From the TEDMED site: “The fifth in a series created by Marc Hodosh and Richard Saul Wurman, TEDMED celebrates conversations that demonstrate the intersection and connections between all things medical and healthcare related: from personal health to public health, devices to design and Hollywood to the hospital.” This year’s speakers include Dean Kamen, Craig Venter, Sanjay Gupta and Goldie Hawn..

2. Transform — September 13–15, http://centerforinnovation.mayo.edu/transform
A collaborative symposium at The Mayo Clinic Center for Innovation. From the Transform site: “Transform brings together a dynamic group of speakers and participants from inside and outside the health care industry to explore the intersections between human experience, health care delivery and new business models. Join us to imagine and create innovative ways to deliver a better health care experience in a 21st century world.”

Continue reading “Top 6 Upcoming Health Events” »

U.S. News and World Report — May 12, 2009, by KEVIN McGILL

BATON ROUGE, La.—Combining human and animal cells to create what are sometimes called “human-animal hybrids” would be a crime in Louisiana, punishable by up to 10 years in prison, under legislation approved Tuesday by a state Senate panel.

Scientific researchers in some areas have tried to create human embryonic stem cells, which scientists say could be used to develop treatment for a variety of human ailments, by placing human DNA into animal cells. But such practices are controversial for a number of reasons.

Continue reading “Dr. Moreau outlawed in LA — Panel Votes to Outlaw Human-Animal Hybrids” »

(Crossposted on the blog of Starship Reckless)

Continue reading “Forever Young” »

May 2: Many U.S. emergency rooms and hospitals crammed with people… ”Walking well” flood hospitals… Clinics double their traffic in major cities … ER rooms turn away EMT cases. — CNN

Update May 4: Confirmed cases of H1N1 virus now at 985 in 20 countries (Mexico: 590, 25 deaths) — WHO. In U.S.: 245 confirmed U.S. cases in 35 states. — CDC.

“We might be entering an Age of Pandemics… a broad array of dangerous emerging 21st-century diseases, man-made or natural, brand-new or old, newly resistant to our current vaccines and antiviral drugs…. Martin Rees bet $1,000 that bioterror or bioerror would unleash a catastrophic event claiming one million lives in the next two decades…. Why? Less forest, more contact with animals… more meat eating (Africans last year consumed nearly 700 million wild animals… numbers of chickens raised for food in China have increased 1,000-fold over the past few decades)… farmers cut down jungle, creating deforested areas that once served as barriers to the zoonotic viruses…” — Larry Brilliant, Wall Street Journal

About

If you ever swore to yourself (or to another) that you’d never get a tattoo, you may just want to reconsider. You may within just a couple of years have a very good reason to get one made out of “nanoink”.

As recently reported on Discovery News, “nanoink” allows for monitoring blood glucose in real-time right under the skin. It does so by using a hydrophobic nanoparticle that changes colors as glucose levels rise and fall. The ink consists of a glucose-detecting molecule, a color changing dye and a molecule that mimics glucose. These three particles continuously swish around inside a 120-nm orb. When glucose is present, the glucose-detecting molecule attaches and glows yellow; if absent, the ink turns orange.

The use of this technology has the advantage over traditional glucose monitoring, of course, in that there is a one-time needle stick for placing the tattoo over the tens of thousands of sticks that a diabetic will need to have over a lifetime.

Another advantage of nanoink tattooing: they can be removed. At least one researcher from Brown University has developed tattoo ink with microencapsulated beads coated with a polymer that when broken with a single laser treatment can simply be expelled from the body, as opposed to multiple laser removal treatments for conventional tattoos.

Continue reading “Detecting Disease by Tattoo” »